HEMO
vs
EXAS
HEMO
EXAS
Over the past 12 months, HEMO has significantly outperformed EXAS, delivering a return of +426% compared to the EXAS's +140% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
HEMO
EXAS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
1 020
GBX
|
|||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
104.91
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
HEMO, EXAS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Hemogenyx Pharmaceuticals PLC
Revenue
|
|||||||||||
|
Exact Sciences Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
HEMO, EXAS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
|||||||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Hemogenyx Pharmaceuticals PLC | ||||
|
Exact Sciences Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
HEMO, EXAS
Performance By Year
HEMO, EXAS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|